tiprankstipranks
Trending News
More News >
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Cash flow

Compare
2,366 Followers

Aquestive Therapeutics Cash Flow

AQST's free cash flow for Q3 2025 was $-12.88M. For the 2025 fiscal year, AQST's free cash flow was decreased by $-28.54M and operating cash flow was $-12.65M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -35.76M$ -6.38M$ -9.79M$ -32.98M$ -45.46M
Investing Cash Flow
$ -159.00K$ -995.00K$ -2.52M$ -913.00K$ -517.00K
Financing Cash Flow
$ 83.59M$ 3.97M$ 11.56M$ 30.11M$ 28.46M
End Cash Position
$ 71.55M$ 23.87M$ 27.27M$ 28.02M$ 31.81M
Free Cash Flow
$ -35.92M$ -7.38M$ -12.31M$ -33.89M$ -45.98M
Currency in USD

Aquestive Therapeutics Cash Flow